SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
35 hedge funds and large institutions have $108M invested in Sinovac Biotech, Ltd in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
Holders
35
Holding in Top 10
1
Calls
$11K
Puts
–
Top Buyers
| 1 | +$15.6M | |
| 2 | +$886K | |
| 3 | +$519K | |
| 4 |
Two Sigma Investments
New York
|
+$432K |
| 5 |
Millennium Management
New York
|
+$320K |
Top Sellers
| 1 | -$31.7M | |
| 2 | -$2.04M | |
| 3 | -$398K | |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$157K |
| 5 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
-$110K |